WHO Issues Warning About The Possible Spike In Super Gonorrhea Due To Excess Use of Antibiotics

The World Health Organization (WHO) has revealed that due to the excessive use of antibiotics during the COVID19 pandemic, there has been a significant increase in the cases of antibiotic-resistant gonorrhea. Antibiotic-resistant gonorrhea is known as super gonorrhea as well. The officials from the WHO have broken the news on social media. They have said that frequently advised antibiotic azithromycin amid the pandemic might be the cause of it. As per the experts, overuse of such antibiotics can lead to incidents of antimicrobial resistance in gonorrhea. It is a sexually transmitted ailment, which affects more than 1 million people in the US every year. Super gonorrhea is linked to strains of the STD, which cannot be treated by common antibiotics. The first cases of super gonorrhea have been identified in Japan in 2011. However, the disease has spread across many countries since then including the US as well. The US Center for Disease Control and Prevention (CDC) as well has said on its website that the disease has become resistant to all except one group of antibiotics. The agency has said that nearly half of new gonorrhea cases have developed resistance to at least one type of antibiotic.
Experts have predicted the prevalence of super gonorrhea in the US after the first case has been reported in the UK. Dr. Bruce Y Lee, a professor at CUNY School of Public Health and Health Policy has said that super gonorrhea is one of the superbugs, which has developed resistance to those drugs, which are used to treat them. In 2017, the WHO as well has included drug defiant gonorrhea in its list of bad superbugs. This disease has always been a matter of concern for health experts, said Dr. Bruce Y Lee. He has said that the spike in the cases of super gonorrhea has been a result of the overuse of an antibiotic called azithromycin during the pandemic. The drug is considered an effective treatment for many health conditions, which has been prescribed, in the early stage of the COVID19 pandemic due to its similarities with pneumonia.
The use of this antibiotic has increased after some experts have said that it should be used along with Hydroxychloroquine, which is an immunosuppressant. However, later, doctors have been asked not to prescribe it to COVID19 patients. He has said that at that time, people have been trying all types of medicines, which have anti-inflammatory properties. Although, studies have not found any benefit of adding azithromycin to standard care for patients who have been hospitalized with the disease. There is no official data, which shows an increase in the cases of super gonorrhea. However, a study from 2018 has shown that cases of azithromycin-resistant gonorrhea have shot up to seven-fold in the last seven years. Considering the findings of this study, the CDC has removed this drug as standard care.